Global Endocrine Testing Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI11243659

Publication Date:

November 29, 2024

Pages:

150

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Endocrine Testing market size was valued at US$ 7497.8 million in 2023. With growing demand in downstream market, the Endocrine Testing is forecast to a readjusted size of US$ 11840 million by 2030 with a CAGR of 6.7% during review period.
The research report highlights the growth potential of the global Endocrine Testing market. Endocrine Testing are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Endocrine Testing. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Endocrine Testing market.
The endocrine system is an integrated network that consists of various glands located throughout the body.
Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency is predicted to boost the demand for endocrine testing.
Key Features:
The report on Endocrine Testing market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Endocrine Testing market. It may include historical data, market segmentation by Type (e.g., Tandem Mass Spectrometry, Immunoassay), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Endocrine Testing market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Endocrine Testing market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Endocrine Testing industry. This include advancements in Endocrine Testing technology, Endocrine Testing new entrants, Endocrine Testing new investment, and other innovations that are shaping the future of Endocrine Testing.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Endocrine Testing market. It includes factors influencing customer ' purchasing decisions, preferences for Endocrine Testing product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Endocrine Testing market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Endocrine Testing market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Endocrine Testing market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Endocrine Testing industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Endocrine Testing market.
Market Segmentation:
Endocrine Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Tandem Mass Spectrometry
Immunoassay
Segmentation by application
Hospitals
Commercial Laboratories
Ambulatory Care Centres
Other Setting
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
AdnaGen
Beckman Coulter/Danaher
Biomedical Diagnostics
BioMerieux
Bio-Rad
Dako
DiaSorin
Eiken
Fujirebio
Instrumentation Laboratory
Kyowa Medex
Matritech
Ortho-Clinical Diagnostics
Roche
Siemens
Sysmex
Thermo Fisher
Tosoh
Wako
Wallac/PE

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Endocrine Testing Market Size 2019-2030
2.1.2 Endocrine Testing Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Endocrine Testing Segment by Type
2.2.1 Tandem Mass Spectrometry
2.2.2 Immunoassay
2.3 Endocrine Testing Market Size by Type
2.3.1 Endocrine Testing Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Endocrine Testing Market Size Market Share by Type (2019-2024)
2.4 Endocrine Testing Segment by Application
2.4.1 Hospitals
2.4.2 Commercial Laboratories
2.4.3 Ambulatory Care Centres
2.4.4 Other Setting
2.5 Endocrine Testing Market Size by Application
2.5.1 Endocrine Testing Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Endocrine Testing Market Size Market Share by Application (2019-2024)
3 Endocrine Testing Market Size by Player
3.1 Endocrine Testing Market Size Market Share by Players
3.1.1 Global Endocrine Testing Revenue by Players (2019-2024)
3.1.2 Global Endocrine Testing Revenue Market Share by Players (2019-2024)
3.2 Global Endocrine Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Endocrine Testing by Regions
4.1 Endocrine Testing Market Size by Regions (2019-2024)
4.2 Americas Endocrine Testing Market Size Growth (2019-2024)
4.3 APAC Endocrine Testing Market Size Growth (2019-2024)
4.4 Europe Endocrine Testing Market Size Growth (2019-2024)
4.5 Middle East & Africa Endocrine Testing Market Size Growth (2019-2024)
5 Americas
5.1 Americas Endocrine Testing Market Size by Country (2019-2024)
5.2 Americas Endocrine Testing Market Size by Type (2019-2024)
5.3 Americas Endocrine Testing Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Endocrine Testing Market Size by Region (2019-2024)
6.2 APAC Endocrine Testing Market Size by Type (2019-2024)
6.3 APAC Endocrine Testing Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Endocrine Testing by Country (2019-2024)
7.2 Europe Endocrine Testing Market Size by Type (2019-2024)
7.3 Europe Endocrine Testing Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Endocrine Testing by Region (2019-2024)
8.2 Middle East & Africa Endocrine Testing Market Size by Type (2019-2024)
8.3 Middle East & Africa Endocrine Testing Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Endocrine Testing Market Forecast
10.1 Global Endocrine Testing Forecast by Regions (2025-2030)
10.1.1 Global Endocrine Testing Forecast by Regions (2025-2030)
10.1.2 Americas Endocrine Testing Forecast
10.1.3 APAC Endocrine Testing Forecast
10.1.4 Europe Endocrine Testing Forecast
10.1.5 Middle East & Africa Endocrine Testing Forecast
10.2 Americas Endocrine Testing Forecast by Country (2025-2030)
10.2.1 United States Endocrine Testing Market Forecast
10.2.2 Canada Endocrine Testing Market Forecast
10.2.3 Mexico Endocrine Testing Market Forecast
10.2.4 Brazil Endocrine Testing Market Forecast
10.3 APAC Endocrine Testing Forecast by Region (2025-2030)
10.3.1 China Endocrine Testing Market Forecast
10.3.2 Japan Endocrine Testing Market Forecast
10.3.3 Korea Endocrine Testing Market Forecast
10.3.4 Southeast Asia Endocrine Testing Market Forecast
10.3.5 India Endocrine Testing Market Forecast
10.3.6 Australia Endocrine Testing Market Forecast
10.4 Europe Endocrine Testing Forecast by Country (2025-2030)
10.4.1 Germany Endocrine Testing Market Forecast
10.4.2 France Endocrine Testing Market Forecast
10.4.3 UK Endocrine Testing Market Forecast
10.4.4 Italy Endocrine Testing Market Forecast
10.4.5 Russia Endocrine Testing Market Forecast
10.5 Middle East & Africa Endocrine Testing Forecast by Region (2025-2030)
10.5.1 Egypt Endocrine Testing Market Forecast
10.5.2 South Africa Endocrine Testing Market Forecast
10.5.3 Israel Endocrine Testing Market Forecast
10.5.4 Turkey Endocrine Testing Market Forecast
10.5.5 GCC Countries Endocrine Testing Market Forecast
10.6 Global Endocrine Testing Forecast by Type (2025-2030)
10.7 Global Endocrine Testing Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Endocrine Testing Product Offered
11.1.3 Abbott Laboratories Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 AdnaGen
11.2.1 AdnaGen Company Information
11.2.2 AdnaGen Endocrine Testing Product Offered
11.2.3 AdnaGen Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 AdnaGen Main Business Overview
11.2.5 AdnaGen Latest Developments
11.3 Beckman Coulter/Danaher
11.3.1 Beckman Coulter/Danaher Company Information
11.3.2 Beckman Coulter/Danaher Endocrine Testing Product Offered
11.3.3 Beckman Coulter/Danaher Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Beckman Coulter/Danaher Main Business Overview
11.3.5 Beckman Coulter/Danaher Latest Developments
11.4 Biomedical Diagnostics
11.4.1 Biomedical Diagnostics Company Information
11.4.2 Biomedical Diagnostics Endocrine Testing Product Offered
11.4.3 Biomedical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Biomedical Diagnostics Main Business Overview
11.4.5 Biomedical Diagnostics Latest Developments
11.5 BioMerieux
11.5.1 BioMerieux Company Information
11.5.2 BioMerieux Endocrine Testing Product Offered
11.5.3 BioMerieux Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BioMerieux Main Business Overview
11.5.5 BioMerieux Latest Developments
11.6 Bio-Rad
11.6.1 Bio-Rad Company Information
11.6.2 Bio-Rad Endocrine Testing Product Offered
11.6.3 Bio-Rad Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Bio-Rad Main Business Overview
11.6.5 Bio-Rad Latest Developments
11.7 Dako
11.7.1 Dako Company Information
11.7.2 Dako Endocrine Testing Product Offered
11.7.3 Dako Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Dako Main Business Overview
11.7.5 Dako Latest Developments
11.8 DiaSorin
11.8.1 DiaSorin Company Information
11.8.2 DiaSorin Endocrine Testing Product Offered
11.8.3 DiaSorin Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 DiaSorin Main Business Overview
11.8.5 DiaSorin Latest Developments
11.9 Eiken
11.9.1 Eiken Company Information
11.9.2 Eiken Endocrine Testing Product Offered
11.9.3 Eiken Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Eiken Main Business Overview
11.9.5 Eiken Latest Developments
11.10 Fujirebio
11.10.1 Fujirebio Company Information
11.10.2 Fujirebio Endocrine Testing Product Offered
11.10.3 Fujirebio Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Fujirebio Main Business Overview
11.10.5 Fujirebio Latest Developments
11.11 Instrumentation Laboratory
11.11.1 Instrumentation Laboratory Company Information
11.11.2 Instrumentation Laboratory Endocrine Testing Product Offered
11.11.3 Instrumentation Laboratory Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Instrumentation Laboratory Main Business Overview
11.11.5 Instrumentation Laboratory Latest Developments
11.12 Kyowa Medex
11.12.1 Kyowa Medex Company Information
11.12.2 Kyowa Medex Endocrine Testing Product Offered
11.12.3 Kyowa Medex Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Kyowa Medex Main Business Overview
11.12.5 Kyowa Medex Latest Developments
11.13 Matritech
11.13.1 Matritech Company Information
11.13.2 Matritech Endocrine Testing Product Offered
11.13.3 Matritech Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Matritech Main Business Overview
11.13.5 Matritech Latest Developments
11.14 Ortho-Clinical Diagnostics
11.14.1 Ortho-Clinical Diagnostics Company Information
11.14.2 Ortho-Clinical Diagnostics Endocrine Testing Product Offered
11.14.3 Ortho-Clinical Diagnostics Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Ortho-Clinical Diagnostics Main Business Overview
11.14.5 Ortho-Clinical Diagnostics Latest Developments
11.15 Roche
11.15.1 Roche Company Information
11.15.2 Roche Endocrine Testing Product Offered
11.15.3 Roche Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Roche Main Business Overview
11.15.5 Roche Latest Developments
11.16 Siemens
11.16.1 Siemens Company Information
11.16.2 Siemens Endocrine Testing Product Offered
11.16.3 Siemens Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Siemens Main Business Overview
11.16.5 Siemens Latest Developments
11.17 Sysmex
11.17.1 Sysmex Company Information
11.17.2 Sysmex Endocrine Testing Product Offered
11.17.3 Sysmex Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Sysmex Main Business Overview
11.17.5 Sysmex Latest Developments
11.18 Thermo Fisher
11.18.1 Thermo Fisher Company Information
11.18.2 Thermo Fisher Endocrine Testing Product Offered
11.18.3 Thermo Fisher Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Thermo Fisher Main Business Overview
11.18.5 Thermo Fisher Latest Developments
11.19 Tosoh
11.19.1 Tosoh Company Information
11.19.2 Tosoh Endocrine Testing Product Offered
11.19.3 Tosoh Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Tosoh Main Business Overview
11.19.5 Tosoh Latest Developments
11.20 Wako
11.20.1 Wako Company Information
11.20.2 Wako Endocrine Testing Product Offered
11.20.3 Wako Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Wako Main Business Overview
11.20.5 Wako Latest Developments
11.21 Wallac/PE
11.21.1 Wallac/PE Company Information
11.21.2 Wallac/PE Endocrine Testing Product Offered
11.21.3 Wallac/PE Endocrine Testing Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Wallac/PE Main Business Overview
11.21.5 Wallac/PE Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂